It appears that 2013 will be the same as 2012 nothing good. Remember when Cp-300 was approved and the stock went down 20%. I guess the fast car and phone booth(better know as Edgemont high) is having a problem with sales of CP-300 and appears that 2or 3 more years are needed for some type REAL SALES.I guess the NDA will be in the second quarter Versus the PROMISED first Quarter! REAL
DEAD MONEY FOR ATLEAST 2or 3 years.
I agree with you jas037. Just look at a couple of things Dr.Zerbe said. He can't disclose the deal with Redhill, but they can. He must not know about it and just agreed with the interviewer not to look bad.
After almost six months he still doesn't know how well Forfivo is doing. If this was your first and major product, don't you think you would be in contact with Edgemont on a weekly basis to see waht was happening? Edgemont was a company of last resort and it is showing.
Profitability in 2013. There is no chance of this. Even if Forfivo does well. they're only going to make maybe $.10 on the dollar. They will probably have a stock offering later this year in the $.15 - $.20 range. A small company like this has to sell their stock at a 30% to 50% discount. So this gives you an idea of where I think this stock is going. Hopefully I'm wrong on the last part, but the way Dr. Zerbe is running this company. I don't think so.
it appears that you don't like the stock
you would do us a big favor to sell your position and come back in 2-3 years
so we can have a discussion about the events of this company based on facts rather than a frustrated kid who did not get his allowance for the week
when you invest in biotech you buy shares to position yourself and wait for the upswing
however if you leave now, you will never know what big drug IGXT is filing